The Muscle Mag
The study, published in the International Journal of Molecular Sciences, contributes to the growing evidence supporting the potential respiratory health benefits of salmon oil.
“We’ve conducted research on the anti-allergenic effects of OmeGo,” stated Dr. Crawford Currie, head of medical R&D at Hofseth BioCare and lead author of the study. He explained that OmeGo’s anti-allergy effects are attributed to fatty acids other than EPA, DPA, or DHA.
OmeGo, sourced from by-products of farmed salmon in Norway by Hofseth BioCare, undergoes minimal processing to retain its nutritional value and stability. Unlike other fish oils, OmeGo is not fractionated or concentrated.
James Berger, chief commercial officer at Hofseth BioCare, emphasized that the production method ensures minimal oxidation, resulting in a stable and nutritious product similar to fresh fish.
The oil contains a variety of fatty acids, antioxidants, and other beneficial compounds beyond EPA and DHA.
From hearts to lungs
OmeGo is targeted for heart, cognitive, eye, and joint health, with studies showing its potential to reduce cardiovascular risk markers and benefit immune and respiratory health.
Recent studies have highlighted OmeGo’s anti-inflammatory and anti-allergenic properties, indicating its potential in treating conditions like asthma.
In a study focused on COVID-19 patients, OmeGo demonstrated inflammation-resolving effects, improved interferon response, and enhanced lung barrier function.
Dr. Currie mentioned plans for a larger study to explore OmeGo’s potential in supporting respiratory health in urban adults, given the importance of air quality.
Source: International Journal of Molecular Sciences 2024, 25 (13), 6917; doi: 10.3390/ijms25136917.
“Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes”
Authors: C. Currie et al.
